A leading neuroscientist, Professor Collingridge’s research focuses on the mechanisms of synaptic plasticity in health and disease, in particular, understanding synaptic plasticity in molecular terms and how pathological alterations in these processes may lead to major disorders, such as Alzheimer’s disease. Professor Collingridge obtained his undergraduate degree in Pharmacology from the University of Bristol and a PhD from the School of Pharmacy at University College London. He was a postdoctoral fellow in the Department of Physiology at the University of British Columbia and in the Department of Physiology and Pharmacology at the University of New South Wales in Sydney Australia.
Professor Collingridge has held visiting Professorships at the University of British Columbia and at Seoul National University. He served as Editor-in-Chief of Neuropharmacology from 1993 until 2010. In 1997 he was elected a Founder Fellow of the European DANA Alliance; and in 1998 he was elected a Founder Fellow of the Academy of Medical Sciences (UK). In 2001 he was elected a Fellow of The Royal Society, and from 2007 until 2009 he served as President of the British Neuroscience Association. Professor Collingridge has won several prizes including the Sharpey-Shafer Prize of the Physiological Society, the Gaddam Memorial Prize of the British Pharmacological Society, and the Feldberg Prize.